GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Alfresa Holdings Corp (TSE:2784) » Definitions » Gross Margin %

Alfresa Holdings (TSE:2784) Gross Margin % : 7.32% (As of Dec. 2023)


View and export this data going back to 2003. Start your Free Trial

What is Alfresa Holdings Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Alfresa Holdings's Gross Profit for the three months ended in Dec. 2023 was 円55,068 Mil. Alfresa Holdings's Revenue for the three months ended in Dec. 2023 was 円751,947 Mil. Therefore, Alfresa Holdings's Gross Margin % for the quarter that ended in Dec. 2023 was 7.32%.

Warning Sign:

Alfresa Holdings Corp gross margin has been in long-term decline. The average rate of decline per year is -1.3%.


The historical rank and industry rank for Alfresa Holdings's Gross Margin % or its related term are showing as below:

TSE:2784' s Gross Margin % Range Over the Past 10 Years
Min: 6.85   Med: 7.2   Max: 7.68
Current: 7.24


During the past 13 years, the highest Gross Margin % of Alfresa Holdings was 7.68%. The lowest was 6.85%. And the median was 7.20%.

TSE:2784's Gross Margin % is ranked worse than
86.46% of 96 companies
in the Medical Distribution industry
Industry Median: 16.37 vs TSE:2784: 7.24

Alfresa Holdings had a gross margin of 7.32% for the quarter that ended in Dec. 2023 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Alfresa Holdings was -1.30% per year.


Alfresa Holdings Gross Margin % Historical Data

The historical data trend for Alfresa Holdings's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alfresa Holdings Gross Margin % Chart

Alfresa Holdings Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.62 7.68 7.00 7.25 7.12

Alfresa Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.08 7.77 6.74 7.15 7.32

Competitive Comparison of Alfresa Holdings's Gross Margin %

For the Medical Distribution subindustry, Alfresa Holdings's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alfresa Holdings's Gross Margin % Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Alfresa Holdings's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Alfresa Holdings's Gross Margin % falls into.



Alfresa Holdings Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Alfresa Holdings's Gross Margin for the fiscal year that ended in Mar. 2023 is calculated as

Gross Margin % (A: Mar. 2023 )=Gross Profit (A: Mar. 2023 ) / Revenue (A: Mar. 2023 )
=192085 / 2696069
=(Revenue - Cost of Goods Sold) / Revenue
=(2696069 - 2503984) / 2696069
=7.12 %

Alfresa Holdings's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=55068 / 751947
=(Revenue - Cost of Goods Sold) / Revenue
=(751947 - 696879) / 751947
=7.32 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Alfresa Holdings  (TSE:2784) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Alfresa Holdings had a gross margin of 7.32% for the quarter that ended in Dec. 2023 => No sustainable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Alfresa Holdings Gross Margin % Related Terms

Thank you for viewing the detailed overview of Alfresa Holdings's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Alfresa Holdings (TSE:2784) Business Description

Traded in Other Exchanges
N/A
Address
1-1-3 Otemachi, Chiyoda-ku, Tokyo, JPN, 100-0004
Alfresa Holdings Corp is a holding company engaged in the distribution of drugs. The company is in the Ethical Pharmaceuticals Wholesaling Business, the Self-Medication Products Wholesaling Business, the Manufacturing Business, and the Medical-Related Business. It mainly provides distributes diagnostic reagents and medical devices/equipment, health foods, supplements and other products to drug stores and pharmacies. The firm manufactures and markets high-quality active pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices.

Alfresa Holdings (TSE:2784) Headlines

No Headlines